CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study

The Lancet HIV

Volumn 2, Issue 3, 2015, Pages e98-e106

  Mussini, C ^h   Lorenzini, P ^h   Cozzi Lepri, A ^h   Lapadula, G ^h   Marchetti, G ^h   Nicastri, E ^h   Cingolani, A ^h   Lichtner, M ^h   Antinori, A ^h   Gori, A ^h   Monforte, Antonella d'Arminio ^e   Moroni, M ^h   Andreoni, M ^h   Angarano, G ^h   d'Arminio Monforte, A ^h   Castelli, F ^h   Cauda, R ^h   Di Perri, G ^h   Galli, M ^h   Iardino, R ^h   Ippolito, G ^h   Lazzarin, A ^h   Perno, C F ^h   von Schloesser, F ^h   Viale, P ^h   Castagna, A ^h   Ceccherini Silberstein, F ^h   Girardi, E ^h   Lo Caputo, S ^h   Puoti, M ^h   Ammassari, A ^h   Balotta, C ^h   Bonfanti, P ^h   Bonora, S ^h   Borderi, M ^h   Capobianchi, M R ^h   Cinque, P ^h   De Luca, A ^h   Di Biagio, A ^h   Gianotti, N ^h   Guaraldi, G ^h   Madeddu, Giordano ^h   Maggiolo, F ^h   Marcotullio, S ^h   Monno, L ^h   Quiros Roldan, E ^h   Rusconi, S ^h   Saracino, A ^h   Cicconi, P ^h   Fanti Galli, I ^h   Tavelli, A ^h   Giacometti, A ^h   Costantini, A ^h   Mazzoccato, S ^h   Santoro, C ^h   Suardi, C ^h   Vanino, E ^h   Verucchi, G ^h   Minardi, C ^h   Quirino, T ^h   Abeli, C ^h   E Manconi, P ^h   Piano, P ^h   Vecchiet, J ^h   Falasca, K ^h   Sighinolfi, L ^h   Segala, D ^h   Mazzotta, F ^h   Cassola, G ^h   Viscoli, C ^h   Alessandrini, A ^h   Piscopo, R ^h   Mazzarello, G ^h   Mastroianni, C ^h   Belvisi, V ^h   Caramma, I ^h   Chiodera, A ^h   Castelli, A P ^h   Rizzardini, G ^h   Ridolfo, A L ^h   Piolini, R ^h   Salpietro, S ^h   Carenzi, L ^h   Moioli, M C ^h   Tincati, C ^h   Puzzolante, C ^h   Abrescia, N ^h   Chirianni, A ^h   Guida, M G ^h   Gargiulo, M ^h   Baldelli, F ^h   Francisci, D ^h   Parruti, G ^h   Ursini, T ^h   Magnani, G ^h   Ursitti, M A ^h   Vullo, V ^h   d'Avino, A ^h   Gallo, L ^h   Acinapura, R ^h   Capozzi, M ^h   Libertone, R ^h   Tebano, G ^h   Cattelan, A ^h   Sasset, L ^h   Mura, M S ^h   Rossetti, B ^h   Caramello, P ^h   Orofino, G C ^h   Sciandra, M ^h   Bassetti, M ^h   Londero, A ^h   Pellizzer, G ^h   Manfrin, V ^h   more..

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d SAN GERARDO HOSPITAL   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f CATHOLIC UNIVERSITY   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; DIDANOSINE; EMTRICITABINE; LAMIVUDINE; STAVUDINE; TENOFOVIR; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; COHORT ANALYSIS; DISEASE COURSE; DISEASE TRANSMISSION; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; NEOPLASM; OBSERVATIONAL STUDY; PRIORITY JOURNAL; VIRUS LOAD; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; ITALY; MIDDLE AGED; PHYSIOLOGY; VIROLOGY;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CD4-CD8 RATIO; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; ITALY; MALE; MIDDLE AGED; VIRAL LOAD;

EID: 84925426479     PISSN: None     EISSN: 23523018     Source Type: Journal    
DOI: 10.1016/S2352-3018(15)00006-5     Document Type: Article

References (31)

1. Bhaskaran K, Hamouda O, Sannes M, et al. Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA 2008, 300:51-59.
2. Mocroft A, Reiss P, Gasiorowski J, et al. Serious fatal and nonfatal non-AIDS-defining illnesses in Europe. J Acquir Immune Defic Syndr 2010, 55:262-270.
3. Sainz T, Serrano-Villar S, Silggi AL, et al. CMV and HIV: a double hit on the CD4/CD8 ratio. Conference on Retroviruses and Opportunistic Infections. March 3-6, 2014; Boston, MA, USA. Abstract 243.
4. Deeks SG HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 2011, 62:141-155.
5. 3. AIDS Res Hum Retroviruses 2013, 29:993-999.
6. Stephan C, Hill A, Xi N, van Delft Y, Moecklinghoff C Is monitoring for CD4 counts still needed for management of patients with long-term HIV-RNA suppression?. J Acquir Immune Defic Syndr 2012, 61:73-75.
7. Hadrup SR, Strindhall J, Kollgaard T, et al. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J Immunol 2006, 176:2645-2653.
8. Wikby A, Johansson B, Ferguson F, Olsson J Age-related changes in immune parameters in very old population of Swedish people: a longitudinal study. Exp Gerontol 1994, 29:531-541.
9. Wikby A, Maxson P, Olsson J, Johansson B, Ferguson FG Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study. Mech Ageing Dev 1998, 102:187-198.
10. 3. Antivir Ther 2009, 14:451-457.
11. Serrano-Villar S, Gutiérrez C, Vallejo A, et al. The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression. J Infect 2013, 66:57-66.
12. Serrano-Villar S, Moreno S, Fuentes-Ferrer M, et al. The CD4:CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infected patients with immunological recovery. HIV Med 2014, 15:40. 39.
13. Serrano-Villar S, Perez-Elias MJ, Dronda F, et al. Increased risk of serious non-AIDS-related events in HIV-infected subjects on antiretroviral therapy associated with a low CD4/CD8 ratio. PLoS One 2014, 1:e85798. 9.
14. Serrano-Villar S, Saiz T, Sulggi AL, et al. HIV infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+T cell activation and increased risk of non-AIDS morbidity and mortality. PLoS Pathog 2014, 10:e1004078.
15. d'Arminio Monforte A, Cozzi-Lepri A, Rezza G, et al. Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naive Patients. AIDS 2000, 14:499-507.
16. Lapadula G, Cozzi-Lepri A, Marchetti G, et al. Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment. AIDS 2013, 27:769-779. for the ICONA foundation study.
17. Tinago W, Coghlan E, Macken A, et al. Clinical, immunological and treatment-related factors associated with normalized CD4+/CD8+ T-cell ratio: effect of naïve and memory T-cell subsets. PLoS One 2014, 9:e97011.
18. Burnham K, Anderson D Model selection and inference. A practical information-theoretical approach 1998, Springer, New York.
19. Marocco R, Lichtner M, Zuccalà P, et al. Predictor factors associated to normalization of CD4/CD8 ratio in HIV suppressed ARV treated patients. 14th European AIDS Clinical Society Conference. Brussels, Belgium; Oct 16-19, 2013. Abstract PE2/10.
20. Lo J, Abbara S, Shturman L, et al. Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men. AIDS 2010, 24:243-253.
21. Leung V, Gillis J, Raboud J, et al. Predictors of CD4:CD8 ratio normalization and its effect on health outcomes in the era of combination antiretroviral therapy. PLoS One 2013, 8:e77665. for the CANOC Collaboration.
22. Gallant JE, DeJesus E, Arribas JR, et al. Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV. N Engl J Med 2006, 354:251-260. for the Study 934 Group.
23. Mocroft A, Lundgren JD, Sabin ML, et al. Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). PLoS Med 2013, 10:e1001510.
24. Lichtner M, Cicconi P, Vita S, et al. HIV and CMV co-infection is associated to increased risk of non AIDS events in a large cohort of HIV-infected patients. J Infect Dis 2015, 211:178-186.
25. Sainz T, Serrano-Villar S, Dìaz L, et al. The CD4/CD8 ratio as a marker of T-cell activation, senescence and activation-exhaustion in treated HIV-infected children and young adults. AIDS 2013, 27:1513-1516.
26. Ferguson FG, Wikby A, Maxson P, Olsson J, Johansson B Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors. J Gerontol A Biol Sci Med Sci 1995, 50:B378-B382.
27. Hadrup SR, Strindhall J, Kollgaard T, et al. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J Immunol 2006, 176:2645-2653.
28. Kuller LH, Tracy R, Belloso W, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008, 5:e203. for the INSIGHT SMART Study Group.
29. Sandler NG, Wand H, Roque A, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis 2011, 203:780-790. for the INSIGHT SMART Study Group.
30. Justice AC, Freiberg MS, Tracy R, et al. Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV?. Clin Infect Dis 2012, 54:984-994. for the VACS Project Team.
31. Tenorio AR, Zheng Y, Bosch RJ, et al. Soluble markers of inflammation and coagulation but not T-cell activation predict non-aids-defining morbid events during suppressive antiretroviral treatment. J Infect Dis 2014, 210:1248-1259.